177 related articles for article (PubMed ID: 15690139)
21. Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.
Eloranta S; Brånvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekström-Smedby K
Eur J Haematol; 2018 Jan; 100(1):61-68. PubMed ID: 28983970
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological correlates of primary central nervous system lymphoma: experience from a tertiary care center in South India.
Patel B; Chacko G; Nair S; Anandan J; Chacko AG; Rajshekhar V; Turel M
Neurol India; 2015; 63(1):77-82. PubMed ID: 25751474
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphomas--new pathological developments.
Jellinger KA; Paulus W
J Neurooncol; 1995; 24(1):33-6. PubMed ID: 8523072
[TBL] [Abstract][Full Text] [Related]
24. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
25. Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.
Enblad G; Martinsson G; Baecklund E; Hesselager G; Sundström C; Amini RM; Hagberg H
Acta Oncol; 2017 Apr; 56(4):599-607. PubMed ID: 28084866
[TBL] [Abstract][Full Text] [Related]
26. Second malignancies in patients with primary central nervous system lymphoma.
Wang J; Pulido JS; O'Neill BP; Johnston PB
Neuro Oncol; 2015 Jan; 17(1):129-35. PubMed ID: 24948826
[TBL] [Abstract][Full Text] [Related]
27. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
28. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
29. Primary central nervous system lymphoma.
Bhagavathi S; Wilson JD
Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
[TBL] [Abstract][Full Text] [Related]
30. Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994-2013).
Fuentes-Raspall R; Solans M; Auñon-Sanz C; Saez M; Marcos-Gragera R
Clin Transl Oncol; 2018 Dec; 20(12):1628-1630. PubMed ID: 29796994
[No Abstract] [Full Text] [Related]
31. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
32. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
33. HIV prevalence in primary central nervous system lymphoma: A systematic review and meta-analysis.
Franca RA; Travaglino A; Varricchio S; Russo D; Picardi M; Pane F; Pace M; Del Basso De Caro M; Mascolo M
Pathol Res Pract; 2020 Nov; 216(11):153192. PubMed ID: 32956921
[TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system lymphoma: a clinicopathological study of 75 cases.
Preusser M; Woehrer A; Koperek O; Rottenfusser A; Dieckmann K; Gatterbauer B; Roessler K; Slavc I; Jaeger U; Streubel B; Hainfellner JA; Chott A
Pathology; 2010; 42(6):547-52. PubMed ID: 20854073
[TBL] [Abstract][Full Text] [Related]
35. A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma.
Tateishi K; Miyake Y; Kawazu M; Sasaki N; Nakamura T; Sasame J; Yoshii Y; Ueno T; Miyake A; Watanabe J; Matsushita Y; Shiba N; Udaka N; Ohki K; Fink AL; Tummala SS; Natsumeda M; Ikegaya N; Nishi M; Ohtake M; Miyazaki R; Suenaga J; Murata H; Aoki I; Miller JJ; Fujii Y; Ryo A; Yamanaka S; Mano H; Cahill DP; Wakimoto H; Chi AS; Batchelor TT; Nagane M; Ichimura K; Yamamoto T
Cancer Res; 2020 Dec; 80(23):5330-5343. PubMed ID: 33067267
[TBL] [Abstract][Full Text] [Related]
36. Primary central nervous system lymphomas: a 30-year experience at a single institution.
Nuckols JD; Liu K; Burchette JL; McLendon RE; Traweek ST
Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
[TBL] [Abstract][Full Text] [Related]
37. Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.
Kumari N; Krishnani N; Rawat A; Agarwal V; Lal P
J Postgrad Med; 2009; 55(4):247-51. PubMed ID: 20083869
[TBL] [Abstract][Full Text] [Related]
38. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
40. [Retrospective study of 48 cases of primary central nervous system lymphoma].
Alessandro L; Pastor Rueda JM; Villalonga JF; Bruno VA; Carpani F; Blaquier JB; Tognarelli S; Varela FJ; Muggeri A
Medicina (B Aires); 2017; 77(1):17-23. PubMed ID: 28140306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
